EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 68 filers reported holding EVELO BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $86,000 | – | 14,194 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 1,763,505 | $21,479,000 | 19.42% |
| Flagship Pioneering Inc. | 18,233,403 | $222,083,000 | 14.68% |
| Alphabet Inc. | 1,060,495 | $12,917,000 | 1.24% |
| SECTORAL ASSET MANAGEMENT INC | 407,171 | $4,959,000 | 0.53% |
| ARK Investment Management | 236,685 | $2,883,000 | 0.09% |
| CREDIT SUISSE AG/ | 888,287 | $10,819,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,931 | $48,000 | 0.00% |
| FMR LLC | 3,264,907 | $38,611,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 89,780 | $1,094,000 | 0.00% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 900 | $11,000 | 0.00% |